Morgan Stanley Maintains on Varian Medical Systems
January 23, 2014 at 10:20 AM EST
In a report published Thursday, Morgan Stanley analyst Steve Beuchaw maintained Underweight on Varian Medical Systems (NYSE: VAR ), with a $71.00 price target. According to the report, orders missed consensus by 3 percent in Oncology and 12 percent overall, though US Oncology rebounded after a weak FY13 to
